Underlying Mechanisms in CADASIL
CADASIL 的底层机制
基本信息
- 批准号:10610849
- 负责人:
- 金额:$ 66.1万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-04-20 至 2025-03-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAffectAgeAgreementAnimal ModelArterial DisorderArteriesBiopsyBiopsy SpecimenBlood VesselsBlood specimenBrainCADASILCaliberCellsCerebral small vessel diseaseCerebrumCharacteristicsClinicClinicalClinical TrialsCollaborationsDataData CorrelationsDementiaDevelopmentDiagnosisDiseaseDisease ProgressionEndotheliumEvaluationEvolutionExtramural ActivitiesFailureFemaleGenerationsGeneticGenotypeGoalsHeadacheHemorrhageImpaired cognitionImpairmentInheritedIschemiaKnowledgeLeadLeukoencephalopathyLifeLinkMolecularMusMutationNOTCH3 geneNatureNerve DegenerationNeurologicNonprofit OrganizationsOrganOutcomeOxygenPathway interactionsPatientsPericytesPhenotypePhysiciansPhysiologicalProcessPrognosisResearchResearch PersonnelRetinaScientistSideSignal TransductionSkinSmooth Muscle MyocytesStrokeSubcortical InfarctionsSubcortical LeukoencephalopathySymptomsTestingTherapeuticTissuesTranslatingTunica MediaUnited States National Institutes of HealthVariantVascular DementiaVascular DiseasesVascular Smooth Musclearterioleautosomeclinical centercognitive functiondeprivationdisease-causing mutationgain of functiongain of function mutationgray matterhuman diseaseimprovedinduced pluripotent stem cellinsightloss of functionmalemonocytemouse modelnotch proteinnovelreceptorrecruitsingle-cell RNA sequencingtargeted treatmenttherapy developmenttranscriptome sequencingtranscriptomic profiling
项目摘要
Brain microvascular ischemic disease is a common cause of leukoencephalopathy, leading to cognitive
impairment, dementia, and stroke. CADASIL (cerebral autosomal dominant arteriopathy with subcortical
infarcts and leukoencephalopathy) is the most frequent mendelian cause of cerebral small vessel
disease. Over two decades ago, disease-causing CADASIL mutations were identified in the receptor
NOTCH3. These mutations result in progressive degeneration of vascular smooth muscle cells in
arterioles. While systemic in nature, the clinical deficits associated with CADASIL manifest primarily in
the brain as a vascular disease, leading to multifocal ischemia with progressive cognitive decline. Despite
its devastating impact on patients, our knowledge of the disease is limited, restricting targeted
therapeutic strategies. A major impediment to progress has been the wide variability in disease
manifestation and a lack of agreement as to whether CADASIL results from a gain or loss of function in
NOTCH3 signaling.
Through a collaborative effort with the NIH Clinical Center, we have made significant strides towards
defining a broader range of clinical read-outs to improve diagnosis and prognosis of CADASIL. We also
gained novel information on molecular changes associated with specific disease-causing mutations
which, at least partially, bring clarity into the broad phenotypic variation. In fact, our findings indicate that
some mutations in NOTCH3 result in suppression of the pathway, while others lead to hyperactivation of
Notch signaling. The objective of this U01 application is to further expand the information related to
clinical presentation, advance the characterization of disease-causing mutations and determine the chief
molecular alterations resulting from these mutations. Furthermore, we will validate animal models to
explore potential avenues for treatment. While a clinical trial is the eventual long-term goal of this
research, a comprehensive understanding of genotype-phenotype relationships with the support of our
colleagues at the NIH Clinical Center is the necessary first step towards this goal. Thus, here our
objective is to test the hypothesis that CADASIL is a broad pleotropic disease caused by both loss and
gain of function mutations in NOTCH3 which mechanistically explain the wide clinical outcomes
associated with vascular degeneration. To test this hypothesis, we present three specific aims: (1) To
develop a robust, multi-organ, longitudinal evaluation of disease progression in a large number of
patients and establish genotype-phenotype relationships; (2) To fully characterize the molecular outcome
of CADASIL mutations as gain or loss of function and associate them with specific molecular read-outs
(3) To explore recently generated animal models representative of both genotype spectra and validate
their utility as potential platforms for therapeutic exploration.
脑微血管缺血性疾病是白质脑病的常见原因,导致认知功能障碍,
损伤痴呆和中风CADASIL(伴有皮质下的常染色体显性遗传性脑动脉病)
脑梗死和白质脑病)是脑小血管病最常见的孟德尔原因。
疾病二十多年前,在受体中发现了导致疾病的CADASIL突变,
NOTCH 3.这些突变导致血管平滑肌细胞的进行性变性,
小动脉虽然本质上是全身性的,但与CADASIL相关的临床缺陷主要表现在
脑血管疾病,导致多灶性缺血,认知能力逐渐下降。尽管
它对患者的破坏性影响,我们对疾病的了解有限,限制了针对性
治疗策略进展的一个主要障碍是疾病的广泛变异性
对于CADASIL是否由以下因素引起的功能获得或丧失,
NOTCH 3信号。
通过与NIH临床中心的合作,我们在以下方面取得了重大进展:
定义更广泛的临床读数,以改善CADASIL的诊断和预后。我们也
获得了与特定致病突变相关的分子变化的新信息
这至少部分地使广泛的表型变异变得清晰。事实上,我们的研究结果表明,
NOTCH 3中的一些突变导致该途径的抑制,而其他突变则导致该途径的过度激活。
陷波信号。本U 01应用程序的目标是进一步扩展与以下内容相关的信息
临床表现,推进致病突变的表征,并确定主要的
由这些突变引起的分子变化。此外,我们将验证动物模型,
探索潜在的治疗途径。虽然临床试验是最终的长期目标,
研究,在我们的支持下全面了解基因型-表型关系
与NIH临床中心的同事合作是实现这一目标的必要的第一步。因此,在这里,我们
目的是检验CADASIL是一种广泛的多效性疾病的假设,
获得NOTCH 3的功能突变,这在机制上解释了广泛的临床结局
与血管变性有关为了验证这一假设,我们提出了三个具体目标:(1)
开发一个强大的,多器官,纵向评估疾病进展,在大量的
患者,并建立基因型-表型关系;(2)充分表征分子结果
CADASIL突变作为功能的获得或丧失,并将其与特定的分子读数相关联
(3)探索最近生成的代表两种基因型谱的动物模型,
它们作为治疗探索的潜在平台的效用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Manfred Boehm其他文献
Manfred Boehm的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Manfred Boehm', 18)}}的其他基金
iPS-technology and patient specific disease models
iPS 技术和患者特定疾病模型
- 批准号:
8746650 - 财政年份:
- 资助金额:
$ 66.1万 - 项目类别:
iPS-technology and patient specific disease models
iPS 技术和患者特定疾病模型
- 批准号:
8939854 - 财政年份:
- 资助金额:
$ 66.1万 - 项目类别:
iPS-technology and patient specific disease models
iPS 技术和患者特定疾病模型
- 批准号:
9157402 - 财政年份:
- 资助金额:
$ 66.1万 - 项目类别:
Vascular remodeling in patients with rare genetic disorders
罕见遗传性疾病患者的血管重塑
- 批准号:
10929131 - 财政年份:
- 资助金额:
$ 66.1万 - 项目类别:
相似海外基金
Hormone therapy, age of menopause, previous parity, and APOE genotype affect cognition in aging humans.
激素治疗、绝经年龄、既往产次和 APOE 基因型会影响老年人的认知。
- 批准号:
495182 - 财政年份:2023
- 资助金额:
$ 66.1万 - 项目类别:
Investigating how alternative splicing processes affect cartilage biology from development to old age
研究选择性剪接过程如何影响从发育到老年的软骨生物学
- 批准号:
2601817 - 财政年份:2021
- 资助金额:
$ 66.1万 - 项目类别:
Studentship
RAPID: Coronavirus Risk Communication: How Age and Communication Format Affect Risk Perception and Behaviors
RAPID:冠状病毒风险沟通:年龄和沟通方式如何影响风险认知和行为
- 批准号:
2029039 - 财政年份:2020
- 资助金额:
$ 66.1万 - 项目类别:
Standard Grant
Neighborhood and Parent Variables Affect Low-Income Preschool Age Child Physical Activity
社区和家长变量影响低收入学龄前儿童的身体活动
- 批准号:
9888417 - 财政年份:2019
- 资助金额:
$ 66.1万 - 项目类别:
The affect of Age related hearing loss for cognitive function
年龄相关性听力损失对认知功能的影响
- 批准号:
17K11318 - 财政年份:2017
- 资助金额:
$ 66.1万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
9320090 - 财政年份:2017
- 资助金额:
$ 66.1万 - 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
10166936 - 财政年份:2017
- 资助金额:
$ 66.1万 - 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
9761593 - 财政年份:2017
- 资助金额:
$ 66.1万 - 项目类别:
How age dependent molecular changes in T follicular helper cells affect their function
滤泡辅助 T 细胞的年龄依赖性分子变化如何影响其功能
- 批准号:
BB/M50306X/1 - 财政年份:2014
- 资助金额:
$ 66.1万 - 项目类别:
Training Grant
Inflamm-aging: What do we know about the effect of inflammation on HIV treatment and disease as we age, and how does this affect our search for a Cure?
炎症衰老:随着年龄的增长,我们对炎症对艾滋病毒治疗和疾病的影响了解多少?这对我们寻找治愈方法有何影响?
- 批准号:
288272 - 财政年份:2013
- 资助金额:
$ 66.1万 - 项目类别:
Miscellaneous Programs